Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,964Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Avycaz

02 4Zavicefta

PharmaCompass

01

Brand Name : Avycaz

arrow
2024 ACI Convention
Not Confirmed

Avibactam

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 117

2018 Revenue in Millions : 95

Growth (%) : 23

Abbvie CB

02

Brand Name : Zavicefta

Avibactam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Zavicefta

arrow
2024 ACI Convention
Not Confirmed

Avibactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 212

2019 Revenue in Millions : 108

Growth (%) : 96

blank

03

Brand Name : Zavicefta

Avibactam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Zavicefta

arrow
2024 ACI Convention
Not Confirmed

Avibactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 413

2020 Revenue in Millions : 212

Growth (%) : 95

blank

04

Brand Name : Zavicefta

Avibactam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Zavicefta

arrow
2024 ACI Convention
Not Confirmed

Avibactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 412

2021 Revenue in Millions : 413

Growth (%) : 0

blank

05

Brand Name : Zavicefta

Avibactam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Zavicefta

arrow
2024 ACI Convention
Not Confirmed

Avibactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 511

2022 Revenue in Millions : 412

Growth (%) : 24

blank